Satsuma Pharmaceuticals Overview
Satsuma Pharmaceuticals Discounted Cash Flow
DCF Analysis for STSA.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.57
Current Fair Value
$1.57
↑ 42.5% Upside
Undervalued by 42.5% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison